Coma Science Group, Cyclotron Research Centre, University of Liège, Sart Tilman, B30, 4000 Liège, Belgium Department of Cognitive Sciences, University of Liège, Liège, Belgium Department of Intensive Care, Centre Hospitalier Universitaire Sart Tilman, Liège, Belgium Department of Neurology, Centre Hospitalier Universitaire Sart Tilman, Sart Tilman, B30, 4000 Liège, Belgium Fund for Scientific Research - FNRS, Belgium Department of Anesthesia, CHU Sart Tilman Hospital, University of Liège, Liège, Belgium.
Pain. 2010 Feb;148(2):215-219. doi: 10.1016/j.pain.2009.09.028. Epub 2009 Oct 24.
Assessing behavioral responses to nociception is difficult in severely brain-injured patients recovering from coma. We here propose a new scale developed for assessing nociception in vegetative (VS) and minimally conscious (MCS) coma survivors, the Nociception Coma Scale (NCS), and explore its concurrent validity, inter-rater agreement and sensitivity. Concurrent validity was assessed by analyzing behavioral responses of 48 post-comatose patients to a noxious stimulation (pressure applied to the fingernail) (28 VS and 20 MCS; age range 20-82 years; 17 of traumatic etiology). Patients' were assessed using the NCS and four other scales employed in non-communicative patients: the 'Neonatal Infant Pain Scale' (NIPS) and the 'Faces, Legs, Activity, Cry, Consolability' (FLACC) used in newborns; and the 'Pain Assessment In Advanced Dementia Scale' (PAINAD) and the 'Checklist of Non-verbal Pain Indicators' (CNPI) used in dementia. For the establishment of inter-rater agreement, fifteen patients were concurrently assessed by two examiners. Concurrent validity, assessed by Spearman rank order correlations between the NCS and the four other validated scales, was good. Cohen's kappa analyses revealed a good to excellent inter-rater agreement for the NCS total and subscore measures, indicating that the scale yields reproducible findings across examiners. Finally, a significant difference between NCS total scores was observed as a function of diagnosis (i.e., VS or MCS). The NCS constitutes a sensitive clinical tool for assessing nociception in severely brain-injured patients. This scale constitutes the first step to a better management of patients recovering from coma.
评估昏迷后严重脑损伤患者的疼痛反应较为困难。我们在此提出一种新的量表,用于评估植物状态(VS)和最小意识状态(MCS)昏迷幸存者的疼痛,即疼痛昏迷量表(NCS),并探索其同时效度、评分者间一致性和敏感性。通过分析 48 例昏迷后患者对疼痛刺激(指甲受压)的行为反应(28 例 VS 和 20 例 MCS;年龄 20-82 岁;17 例创伤性病因)来评估同时效度。使用 NCS 以及其他四种用于非交流患者的量表评估患者:新生儿疼痛量表(NIPS)和用于新生儿的“面部、腿部、活动、哭泣、安慰”(FLACC);以及用于痴呆患者的疼痛评估高级痴呆量表(PAINAD)和非语言疼痛指标检查表(CNPI)。为了建立评分者间一致性,15 例患者由两位评估者同时进行评估。通过 NCS 与其他四种已验证量表之间的 Spearman 秩相关来评估同时效度,结果良好。Cohen's kappa 分析显示 NCS 总分和子评分的评分者间一致性良好到极好,表明该量表在评分者之间可产生可重复的结果。最后,NCS 总分的差异随着诊断(即 VS 或 MCS)而显著。NCS 是评估严重脑损伤患者疼痛的敏感临床工具。该量表是改善昏迷后患者管理的第一步。